drug company funding for drug trials is leading to biased findings and inappropriate prescribing

July 2004

There's growing concern that drug company funding for drug trials is leading to biased findings and inappropriate prescribing.

In May we told you how physicians select one drug over another based on the way statistics are used and how study results are presented.

Now the AMA just launched a campaign to draw attention to "publication bias"...and get gov't help to curb these practices.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: PA includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote